-
Tysabri And PML: No New Reports Of Serious Brain Infection PML According To Biogen And Elan
Drug Companies Also State There Have Been No Reports Of Other "Serious Opportunistic Infections" Related To Recent Use Of Tysabri (Posted by Tom Lamb at DrugInjuryWatch.com) In a May 3, 2007 Wall Street Journal…
-
May 2007 FDA “Patient Safety News” Videos For Doctors Online
Covers Procrit, Aranesp & Epogen, As Well As Adderall, Ambien, And More (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA’s Patient Safety News (PSN) is a series of monthly video news shows intended primarily…
-
More Than One Million Hospitalized Patients Experienced Adverse Drug Reactions (ADRs) In 2004
Findings Of April 2007 AHRQ Report On Side Effects And Other Medication Problems In American Hospitals (Posted by Tom Lamb at DrugInjuryWatch.com) A recent online article provided a summary of the findings from the…
-
Former FDA Physician David Ross Criticizes Agency’s Handling Of Ketek Case In April 2007 NEJM Article
FDA Staffers’ Letter To Editor Defends Steps Taken Over Time As Regards This Controversial Sanofi-Aventis Antibiotic (Posted by Tom Lamb at DrugInjuryWatch.com) In the April 19, 2007 New England Journal of Medicine (NEJM) appears…
-
Significant Increase In Deaths For Aranesp Users In Comparison To Patients Taking Placebo
Amgen-Sponsored Study Was Testing Aranesp In Cancer Patients Who Developed Anemia (Posted by Tom Lamb at DrugInjuryWatch.com) An April 17, 2007 Wall Street Journal (WSJ) article about the results of a new study concerning…
-
Vioxx Judge Wilson In Texas Might Rule For Merck On Preemption Issue And Dismiss Ledbetter Case
WSJ Reports That Judge Wilson’s Ruling In This One Vioxx Case Could Affect Other 1000 Texas Vioxx Cases (Posted by Tom Lamb at DrugInjuryWatch.com) Reporter Heather Won Tesoriero broke the news in an April…
